London
· Delayed Price · Currency is GBP · Price in GBXLife Science REIT Statistics
Total Valuation
Life Science REIT has a market cap or net worth of GBP 129.50 million. The enterprise value is 234.04 million.
| Market Cap | 129.50M |
| Enterprise Value | 234.04M |
Important Dates
The last earnings date was Thursday, September 26, 2024.
| Earnings Date | Sep 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Life Science REIT has 350.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 350.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 88.85% |
| Float | 326.33M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 24.45 |
| PS Ratio | 6.44 |
| PB Ratio | 0.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.45 |
Enterprise Valuation
| EV / Earnings | -5.85 |
| EV / Sales | 11.63 |
| EV / EBITDA | n/a |
| EV / EBIT | 24.82 |
| EV / FCF | -12.90 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.44.
| Current Ratio | 1.20 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.51 |
| Interest Coverage | 0.92 |
Financial Efficiency
Return on equity (ROE) is -13.77% and return on invested capital (ROIC) is 1.47%.
| Return on Equity (ROE) | -13.77% |
| Return on Assets (ROA) | 1.40% |
| Return on Capital (ROIC) | 1.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.62% in the last 52 weeks. The beta is 0.09, so Life Science REIT's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -43.62% |
| 50-Day Moving Average | 39.01 |
| 200-Day Moving Average | 37.88 |
| Relative Strength Index (RSI) | 33.56 |
| Average Volume (20 Days) | 684,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Life Science REIT had revenue of GBP 20.12 million and -40.04 million in losses. Loss per share was -0.11.
| Revenue | 20.12M |
| Gross Profit | 14.51M |
| Operating Income | 9.43M |
| Pretax Income | -40.29M |
| Net Income | -40.04M |
| EBITDA | n/a |
| EBIT | 9.43M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 13.53 million in cash and 118.07 million in debt, giving a net cash position of -104.54 million or -0.30 per share.
| Cash & Cash Equivalents | 13.53M |
| Total Debt | 118.07M |
| Net Cash | -104.54M |
| Net Cash Per Share | -0.30 |
| Equity (Book Value) | 267.23M |
| Book Value Per Share | 0.76 |
| Working Capital | 2.66M |
Cash Flow
In the last 12 months, operating cash flow was 11.78 million and capital expenditures -29.92 million, giving a free cash flow of -18.15 million.
| Operating Cash Flow | 11.78M |
| Capital Expenditures | -29.92M |
| Free Cash Flow | -18.15M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 72.13%, with operating and profit margins of 46.87% and -198.99%.
| Gross Margin | 72.13% |
| Operating Margin | 46.87% |
| Pretax Margin | -200.20% |
| Profit Margin | -198.99% |
| EBITDA Margin | n/a |
| EBIT Margin | 46.87% |
| FCF Margin | -90.17% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 5.22%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 5.22% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 5.22% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |